SUPER
  1. Home
  2. Stocks
  3. SEARL
  4. News and notes

SEARL · PHARMACEUTICALS

SEARL news and notes The Searle Company Limited

The Searle Company Limited (SEARL) news and notes: the SuperX note and what changed (6 items). The note is written by SuperX’s AI from its own figures. What changed is listed newest first.

What SuperX wrote about SEARL

  1. On 10 Nov the price rose 5.35% on 3.65 times the usual volume. The sector and the index also rose that day.

  2. The next results are for the half-year ending 31 Dec. Last year the company filed these results on 26 Feb.

  3. The price is 41.35% below its 52-week high and 7.77% above its 52-week low.

Written by SuperX’s analyst desk from SuperX’s own figures, from the close of 13 Nov 2026. Each number was checked against those figures. Not advice.

What changed for SEARL, newest first

  • 13 Nov 2026Closed 79.22, -0.39%. Volume 635,585, 0.5 times the average of the 30 sessions before it, 1.36 m.
  • 12 Nov 2026Margin financing (MTS) open on SEARL: 4,332,178 shares.
  • 10 Nov 2026Trend read changed to sideways: above the 50-day average, below the 200-day; down 12.2% over 3 months; fell 45.6% from its 1-year peak at worst.
  • 21 Oct 2026Quarter ended 30 Sep 2026: earnings per share Rs 1.47, sales Rs 8.5 bn, up 1.4% on the same quarter a year before.
  • 5 Oct 2026Latest dealing filed: purchase of 5,000 shares at Rs 76.65. Filed for: major owner.
  • NextHalf-year results (to 31 Dec 2026) expected 23 Feb 2027 – 5 Mar 2027, a projection. An estimate from the dates of the last 8 filings.

As of the close of 13 Nov 2026. Closes and notices: PSX. Margin financing: NCCPL. Trend read: SuperX, from daily closes. Volume: against the average of the 30 sessions before the last. Next results: an estimate from the dates of the last 8 filings. Not advice.

More on SEARL

Data from PSX via SuperX, delayed and provided for information only — not investment advice. Figures may contain errors; verify with your broker before acting. As of .